Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Open accessThe DOI matches its Crossref record; 169 of the 170 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder of the cortex and hippocampus, which eventually leads to cognitive impairment. Although the etiology of AD remains unclear, the presence of β ‐amyloid (A β ) peptides in these learning and memory regions is a hallmark of AD. Therefore, the inhibition of A β peptide aggregation has been considered the primary therapeutic strategy for AD treatment. Many studies have shown that resveratrol has antioxidant, anti‐inflammatory, and neuroprotective properties and can decrease the toxicity and aggregation of A β peptides in the hippocampus of AD patients, promote neurogenesis, and prevent hippocampal damage. In addition, the antioxidant activity of resveratrol plays an important role in neuronal differentiation through the activation of silent information regulator‐1 (SIRT1). SIRT1 plays a vital role in the growth and differentiation of neurons and prevents the apoptotic death of these neurons by deacetylating and repressing p53 activity; however, the exact mechanisms remain unclear. Resveratrol also has anti‐inflammatory effects as it suppresses M1 microglia activation, which is involved in the initiation of neurodegeneration, and promotes Th2 responses by increasing anti‐inflammatory cytokines and SIRT1 expression. This review will focus on the antioxidant and anti‐inflammatory neuroprotective effects of resveratrol, specifically on its role in SIRT1 and the association with AD pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Main cellular routes proposed for the mechanisms of resveratrol in Alzheimer's disease. Modified from Ma et al. [72].](https://figures.cochat.ai/paper-figures/298b13e31ae74366bf246f40fc9ced35/neuroprotective-mechanisms-of-resveratrol-in-alzheimers-disease-role-of-sirt1-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, SIRT1 inhibits Aβ production and neuroinflammation and prevents neuronal apoptosis in AD models.414”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [414]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
Donmez, G., Wang, D., Cohen, D. E., & Guarente, L. (2010) · Cell · doi:10.1016/j.cell.2010.06.020 · Cited by 432
RetractedMarwarha, G., Raza, S., Meiers, C., & Ghribi, O. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.015 · Cited by 107
RetractedSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796 · cited 1×
“Some studies have reported that resveratrol is an activator of SIRT1 [27, 69], although further evidence shows that resveratrol is not a direct activator of SIRT1 [70], and that its role may be related to the activation of substrates of SIRT1 [71].”
BackgroundAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 7×
“Some neurodegenerative diseases, such as AD, are associated with oxidative stress and neuroinflammation, and proteins that are closely related to this neurological disorder (i.e., AMPK, SIRT1, and PGC-1α) can be modulated by resveratrol [152]; however, there are few clinical studies on resveratrol in AD patients.”
BackgroundInfluentialModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 1×
“vation and had strong neuroprotective effects [68, 155].”
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 1×
“However, oxidative stress is also an important event in the pathogenesis of AD [89], as the generation and accumulation of ROS and reactive nitrogen species can accelerate fibrillization, increase the toxicity of Aβ, and promote neuronal death and neurodegeneration [90–93].”
BackgroundHIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Price, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602 · cited 1×
“Thus, showing a dose-dependent effect, resveratrol was able to activate AMPK independently of SIRT1 [116].”
BackgroundResveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Cited by
Items 201–300 of 401
Yang, Q., Chen, D., Li, C., Liu, R., & Wang, X. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1399154 · Cited by 21
Ji, S.-B., Park, S., Bae, S., Seo, H.-J., Kim, S.-E., Lee, G.-M., Wu, Z., & Liu, K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091419 · Cited by 18
Afewerky, H. K., Li, H., Zhang, T., Li, X., Mahaman, Y. A. R., Duan, L., Qin, P., Zheng, J., Pei, L., & Lu, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-05568-2 · Cited by 19
Hao, K., Chen, F., Zhao, L., Xu, S., Xiong, Y., Xu, R., Xie, X., Huang, H., Shu, C., Liu, Z., et al. (2023) · Schizophrenia · doi:10.1038/s41537-023-00357-w · Cited by 20
Yadav, V., Mythri, C., & Kumarasamy, M. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100048 · Cited by 28
D’Incal, C. P., Dijck, A. V., Ibrahim, J., Man, K. D., Bastini, L., Konings, A., Elinck, E., Theys, C., Gozes, I., Marušić, Z., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01743-w · Cited by 22
“Similar to ADNP, SIRT1 regulates autophagy and mitochondrial functions [49], maintains genomic stability [45], enhances synaptic plasticity [46], suppresses inflammation [47], regulates cellular aging [48] and promotes neuroprotection [97].”
BackgroundCeccarelli, D. C., & Solerte, S. B. (2025) · Metabolites · doi:10.3390/metabo15030159 · Cited by 21
“Resveratrol [11,12] Activates SIRT1.”
Testa, G., Giannelli, S., Sottero, B., Staurenghi, E., Giaccone, G., Caroppo, P., Gamba, P., & Leonarduzzi, G. (2023) · Antioxidants · doi:10.3390/antiox12030631 · Cited by 22
“For example, the grape antioxidant resveratrol, which is considered to be an activator of SIRT1 [93], has also been shown to modulate Nrf2-dependent antioxidant protein expression promoting neuroprotection against cerebral ischemic injuries [94].”
BackgroundStem cells in the treatment of Alzheimer's disease – Promises and pitfalls
Bhatti, J. S., Khullar, N., Mishra, J., Kaur, S., Sehrawat, A., Sharma, E., Bhatti, G. K., Selman, A., & Reddy, P. H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166712 · Cited by 22
Advancements in autophagy perturbations in Alzheimer’s disease: Molecular aspects and therapeutics
Dhapola, R., Kumari, S., Sharma, P., Vellingiri, B., & HariKrishnaReddy, D. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149494 · Cited by 17
Alarcón‐Espósito, J., Mallea, M., & Rodríguez-Lavado, J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200914155951 · Cited by 26
“production, and Aβ expression in AD patients brains [170].”
BackgroundInfluentialImpact of dietary polyphenols on neuroinflammation-associated disorders
Revi, N., & Rengan, A. K. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05303-1 · Cited by 19
“SIRT1 is a well-studied sirtuin known to downregulate NFκB mediated neuroinflammation [62, 63].”
BackgroundPterostilbene: A natural neuroprotective stilbene with anti-Alzheimer's disease properties
Gao, S., Zhang, H., Li, N., Zhang, L., Zhu, Z., & Xu, C. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101043 · Cited by 21
“Recently, both in vivo and in vitro AD model experiments have demonstrated that activating SIRT1 can protect nerves through anti-in fl ammatory and anti-apoptosis effects as well as by reducing amyloid protein accumulation [137 e 139].”
Glial Cells in the Early Stages of Neurodegeneration: Pathogenesis and Therapeutic Targets
Ahremenko, E. A., Andreev, A., Apushkin, D., & Korkotian, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411995 · Cited by 23
“Resveratrol, a plant-derived polyphenol, activates sirtuin-1 (SIRT1), a nicotinamide adenine dinucleotide–dependent deacetylase that regulates energy metabolism, aging, oxidative-stress responses, and inflammatory pathways, thereby inhibiting microglial M1 transformation [93,94].”
Effects of Redox Homeostasis and Mitochondrial Damage on Alzheimer’s Disease
Wu, Y., & Hsieh, H. (2023) · Antioxidants · doi:10.3390/antiox12101816 · Cited by 17
“Resveratrol could upregulate SIRT1, ERK, and AMPK (PGC-1 α ) signaling to further contribute to mitochondrial functions and improve neuronal renewal [150].”
Resveratrol and Neuroinflammation: Total-Scale Analysis of the Scientific Literature
dos Santos, M. G., da Luz, D. B., de Miranda, F. B., de Aguiar, R. F., Siebel, A. M., Arbo, B. D., & Hort, M. A. (2024) · Nutraceuticals · doi:10.3390/nutraceuticals4020011 · Cited by 20
Hydrogen Sulfide Inhibits Homocysteine-Induced Neuronal Senescence by Up-Regulation of SIRT1
Kang, X., Li, C., Xie, X. S., Zhan, K., Yang, S., Tang, Y.-Y., Zou, W., Zhang, P., & Tang, X. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.38602 · Cited by 17
Yan, D., Gao, L., Lang, J., Gao, X., & Ma, H. (2021) · Environmental Toxicology · doi:10.1002/tox.23294 · Cited by 17
A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer’s Disease
Chen, H., Chen, F., Zhang, M., Chen, Y., Cui, L., & Liang, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210602 · Cited by 15
Gao, L., Yang, X.-N., Dong, Y., Han, Y., Zhang, X., Zhou, X.-L., Liu, Y., Liu, F., Fang, J., Ji, J., et al. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108751 · Cited by 19
Kreiner, G., Soenmez, A., Liss, B., & Parlato, R. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00106 · Cited by 17
“More recently a putative anti-oxidant and anti-inflammatory neuroprotective mechanism has been linked to SIRT1 activation in AD (Gomes et al., 2018).”
BackgroundRahman, M. A., Rahman, M. S., Rahman, M. H., Rasheduzzaman, M., Mamun-Or-Rashid, A. N. M., Uddin, M. J., Rahman, M. R., Hwang, H., Pang, M., & Rhim, H. (2020) · Preprints.org · doi:10.20944/preprints202010.0195.v1 · Cited by 15
“A polyphenol resveratrol is being considered widely because of its use in AD model [117].”
Ormazabal, P., Bastías-Pérez, M., Inestrosa, N. C., & Cisternas, P. (2025) · Pharmaceuticals · doi:10.3390/ph18101527 · Cited by 18
“Notably, clinical trials with resveratrol have shown mixed results, possibly due to poor bioavailability; however, adiponectin modulation remains a consistent biomarker of its metabolic actions [236–238].”
Dagla, I., Gkikas, F., Gikas, E. E., & Tsarbopoulos, A. (2026) · Cells · doi:10.3390/cells15030295 · Cited by 18
“Resveratrol can penetrate the blood–brain barrier, and thus, it enhances endogenous antioxidant enzymes and activates silent information regulator-1 (SIRT1) that plays a crucial role in growth, differentiation, and apoptotic death of neurons by suppressing p53 activity [61,62].”
Canedo‐Santos, J. C., Carrillo-Garmendia, A., Mora‐Martinez, I., Gutierrez‐Garcia, I. K., Ramirez‐Romero, M. G., Regalado‐González, C., Nava, G. M., & Pérez, L. A. M. (2021) · Yeast · doi:10.1002/yea.3677 · Cited by 17
“Notably, several studies have reported the antioxidant response occasioned by resveratrol (Gomes et al., 2018; Silva et al., 2019).”
BackgroundZhao, X.-Y., Dong, Y. J., Shi, X., Hou, S., & Teng, D. (2022) · Neuroreport · doi:10.1097/wnr.0000000000001805 · Cited by 13
Atoki, A. V., Aja, P. M., Ondari, E. N., & Shinkafi, T. S. (2023) · International Journal of Food Properties · doi:10.1080/10942912.2023.2243050 · Cited by 21
He, Y., Zhou, C., Jiang, S., Lan, W.-Q., Zhang, F., Tao, X., & Chen, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1292807 · Cited by 15
Emerging pharmacological approaches for Huntington's disease
Singh, K., Jain, D., Sethi, P., Gupta, J. K., Tripathi, A. K., Kumar, S., Sarker, S. D., Nahar, L., & Guru, A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176873 · Cited by 18
Zeng, Y., Shi, Y., Zhan, H., Liu, W., Cai, G., Zhong, H., Wang, Y., Chen, S., Huang, S., & Wu, W. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00017 · Cited by 15
“In the nervous system, SIRT1 suppress the neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease via anti-apoptosis, anti-inflammation (Singh et al., 2017; Gomes et al., 2018).”
BackgroundQiu, Z., Yu, J., Dai, Y., Yang, Y., Lu, X., Xu, J., Qin, Z., Huang, F., & Li, N. (2017) · Biomedical Chromatography · doi:10.1002/bmc.4001 · Cited by 14
The miR-34a-5p Promotes Hippocampal Neuronal Ferroptosis in Epilepsy by Regulating SIRT1
Gao, F., Yang, Z., & Li, J. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04378-y · Cited by 16
Zhou, Q., Deng, Y., Hu, X., & Xu, Y. (2021) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2021.5997 · Cited by 13
“Similarly, RES can regulate neuronal growth and differentiation through SIRT1 and prevent neuronal apoptosis by inhibiting p53 activity in Alzheimer’s disease [14].”
BackgroundWang, X., Wu, J., Ma, S., Xie, Y., Liu, H., Yao, M., Zhang, Y.-T. Y., Yang, G. L., Yang, B., Guo, R., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00062 · Cited by 15
“(Gomes et al., 2018).”
RetractedHu, Y., Zhang, Q., Wang, J., Wang, J., Liu, Y., Zhu, L., & Xu, J. (2023) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12643 · Cited by 13
“In addition, RSV also has a protective effect on nerve cells in neurodegenerative diseases such as Alzheimer's disease.(9,11,12)”
BackgroundResveratrol: Protective Agent Against Alzheimer’s Disease
Subhan, I., & Siddique, Y. H. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249287167240222081517 · Cited by 14
Neuroprotective effects of ZL006 in Aβ1–42-treated neuronal cells
Tao, W., Yu, L., Jiang, S., Cao, X., Chen, J., Bao, X.-Y., Li, F., Xu, Y., & Zhu, X.-L. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.285006 · Cited by 14
“Resveratrol upregulates the activity of sirtuin 1 and attenuates spatial memory impairment and synaptic dysfunctions in Aβ1–42-treated rats (Gomes et al., 2018).”
BackgroundMoreira, N. C. D. S., Tamarozzi, E. R., Lima, J. E. B. D. F., Piassi, L. D. O., Carvalho, I., Passos, G. A. S., & Sakamoto‐Hojo, E. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314788 · Cited by 12
Allen, A. R., Jones, A., LoBianco, F. V., Krager, K. J., & Aykin‐Burns, N. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114335 · Cited by 13
Akantibila, M., & Carabetta, V. J. (2025) · Pharmaceuticals · doi:10.3390/ph18111723 · Cited by 14
“The overexpression of SIRT1 in animal models reduced the production of A β and A β plaque formation while deleting SIRT1 increased A β levels [183].”
Yin, F., Zhang, J., Liu, Y., Zhai, Y., Luo, D., Yan, X., Feng, Y., Lai, J., Zheng, H., Wei, S., et al. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac040 · Cited by 12
Luo, Y., Hu, N., Zhao, Y., Lai, J., Luo, X., & Liu, J. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12132 · Cited by 14
Gopalakrishna, R., Aguilar, J., Oh, A., Lee, E., Hou, L., Lee, T., Xu, H. E., Nguyen, J., & Mack, W. J. (2024) · FEBS Letters · doi:10.1002/1873-3468.14835 · Cited by 12
“Others have reviewed that t -RES requires 5 – 100 l M concentrations to bind various cellular targets and induce cellular actions in vitro , much higher than t -RES reached in the tissues [3,27].”
BackgroundDziewa, M., Złotek, M., Herbet, M., & Piątkowska‐Chmiel, I. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01514-0 · Cited by 12
Vahid, Z. F., Eskandani, M., Dadashi, H., Vandghanooni, S., & Rashidi, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40756 · Cited by 19
Apiraksattayakul, S., Pingaew, R., Prachayasittikul, V., Ruankham, W., Tantimongcolwat, T., Prachayasittikul, V., Prachayasittikul, S., & Phopin, K. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04281-y · Cited by 13
Pandya, K., Roul, K., Tripathi, A., Belemkar, S., Sinha, A., Erol, M., & Kumar, D. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00207 · Cited by 12
Resveratrol and Curcumin for Chagas Disease Treatment—A Systematic Review
Imperador, C. H. L., Scarim, C. B., Bosquesi, P. L., Lopes, J. R., Neto, A. C., Giarolla, J., Ferreira, E. I., dos Santos, J. L., & Chin, C. M. (2022) · Pharmaceuticals · doi:10.3390/ph15050609 · Cited by 12
Poddar, N. K., Agarwal, D., Agrawal, Y., Wijayasinghe, Y. S., Mukherjee, A., & Khan, S. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166524 · Cited by 11
Zamani, M., Mokarram, P., Jamshidi, M., Siri, M., & Ghasemi, H. (2023) · Current Computer - Aided Drug Design · doi:10.2174/0115734099258321231003161602 · Cited by 9
Regulation of aging-related chronic diseases by dietary polyphenols: An updated overview
Liu, J., Dong, K., Deng, Q., Zou, Z., Chen, S., Feng, N., Wang, J., Huang, H., & Wu, Q. (2025) · Current Research in Food Science · doi:10.1016/j.crfs.2025.101163 · Cited by 10
“Meanwhile, polyphenols activate AMPK to induce the expression of PGC-1 α , which promotes mitochondrial biogenesis and achieves mitochondrial mass control (Gomes et al., 2018).”
Perus, L., Busto, G. U., Mangin, J., Bars, E. L., & Gabelle, A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1014559 · Cited by 13
“Resveratrol has been shown to increase brain neurogenesis (Gomes et al., 2018), decrease amyloid deposition (Ashrafizadeh et al.”
BackgroundMuscadine, Resveratrol (RSV) Synthesis, and the Nutritional Benefits to Humans and Plants
Stewart, J. A., Pajerowska-Mukhtar, K. M., Bulger, A., Kambiranda, D. M., Nyochembeng, L. M., & Mentreddy, S. R. (2023) · ACS Food Science & Technology · doi:10.1021/acsfoodscitech.2c00176 · Cited by 10
Zhang, Y., Wei, R., Zhang, M., Zhang, K.-X., Zhang, J.-Y., Fang, S., Ge, Y., Kong, X.-Y., Chen, G.-H., & Li, X. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1271653 · Cited by 10
Ginseng and Polygonum multiflorum formula protects brain function in Alzheimer’s disease
Liu, J., Wei, F., Wang, Y., Liu, J., Xu, B., Ma, S., & Yang, J.-B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1461177 · Cited by 15
Mitochondrial drug delivery systems
Hubbard, W. B., Vekaria, H. J., & Sullivan, P. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00017-6 · Cited by 9
Potential drugs for the treatment of Alzheimer’s disease
Montero-Cosme, T. G., Pascual-Mathey, L. I., Hernández‐Aguilar, M. E., Herrera‐Covarrubias, D., Rojas-Durán, F., & Aranda-Abreu, G. E. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00481-5 · Cited by 8
“Furthermore, it helps to reduce oxidative stress and mitophagy-mediated mitochondrial damage in cell models previously stimulated with Aβ, which increases resistance against neuroinflammation [14, 47].”
BackgroundSamal, M., Srivastava, V., Khan, M., Insaf, A., Penumallu, N. R., Alam, A., Parveen, B., Ansari, S. H., & Ahmad, S. (2024) · Phytotherapy Research · doi:10.1002/ptr.8344 · Cited by 9
Gentile, G., Paciello, F., Zorzi, V., Spampinato, A. G., Guarnaccia, M., Crispino, G., Tettey‐Matey, A., Scavizzi, F., Raspa, M., Fetoni, A. R., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.616878 · Cited by 10
“Moreover, the potent natural antioxidant and anti-inflammatory resveratrol is known to act on Sirt1, with positive antiaging effects on both brain (Sarubbo et al., 2017; Gomes et al., 2018) and vasculature (Kida and Goligorsky, 2016), also protecting vascular endothelial cells from atherosclerosis (a chronic inflammat…”
BackgroundNeuroprotective Effects of Piceatannol on Olfactory Bulb Injury after Subarachnoid Hemorrhage
Akar, A., Öztopuz, Ö., Büyük, B., Ovalı, M. A., Aykora, D., & Malçok, Ü. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03306-x · Cited by 8
Zarneshan, S. N., Fakhri, S., Kiani, A., Abbaszadeh, F., Hosseini, S. Z., Noori, E. M., & Echeverría, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1574323 · Cited by 11
Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 mice
Goodland, M. N., Banerjee, S., Niehoff, M. L., Young, B. J., Macarthur, H., Butler, A. A., Morley, J. E., & Farr, S. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0296586 · Cited by 10
“Indeed, treatments with antioxidant properties have also been shown to improve memory in rodent models of AD including the SAMP8 mouse [42–44].”
Chen, H., Yao, M., Li, Z., Xing, R., Zhang, C., Dai, Y., Yin, X., Tang, J., & Huang, H. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2285707 · Cited by 10
Li, Y., Zhang, W., Zhang, Q., Li, Y., Xin, C., Tu, R., & Yan, H. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110283 · Cited by 13
Tetrahydroxystilbene glucoside alleviates angiotensin II induced HUVEC senescence via SIRT1
Fan, W., Guo, Y., Cao, S., Cao, S., Xie, Y., Liu, X., & Jin, B. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0202 · Cited by 7
Cracco, P., Montalesi, E., Parente, M., Cipolletti, M., Iucci, G., Battocchio, C., Venditti, I., Fiocchetti, M., & Marino, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065903 · Cited by 7
Ageing, Metabolic Dysfunction, and the Therapeutic Role of Antioxidants
Santos, A. L., & Sinha, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-26576-1_15 · Cited by 8
Irnidayanti, Y., Sutiono, D. R., Ibrahim, N., Wisnuwardhani, P. H., & Santoso, A. (2022) · Brazilian Journal of Biology · doi:10.1590/1519-6984.235781 · Cited by 9
SHARMA, A. K., Mannan, A., & Singh, T. G. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01642-6 · Cited by 9
“SIRT1 may influence Aβ metabolism by affecting the processing of APP, and loss of SIRT1 is closely linked to enhanced Aβ production (Gomes et al. 2018 ).”
Singh, K., Gupta, J. K., Sethi, P., Mathew, S., Bhatt, A., Sharma, M. C., Saha, S., Khan, S., & Kumar, S. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266305736240725052825 · Cited by 21
Rodkin, S., Dzreyan, V., Demyanenko, S. V., & Uzdensky, A. B. (2021) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s199074782106009x · Cited by 6
The effect of resveratrol on lead-induced oxidative damage and apoptosis in HT-22 cells
Xiang, Y., Wei, R., Huang, S., Wei, P., Li, H., Li, Z., Aschner, M., Jiang, Y., Ou, S., & Li, S. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115274 · Cited by 8
Askarova, S., Sitdikova, K., Kassenova, A., Chaprov, K., Svirin, E. P., Tsoy, A., de Munter, J., Вячеславовна, Г. А., Litavrin, A., Deykin, A. V., et al. (2025) · Antioxidants · doi:10.3390/antiox14070834 · Cited by 10
“Sirt1 expression, which is associated with longevity and neuroprotection [45,46], was significantly elevated in the hippocampi of APP/PS1 mice treated with fullerene and fullerenol, indicating a potential restorative effect in AD models.”
Therapeutic Potential of Resveratrol in Cancer and Neurodegenerative Disorders: A Current Review
Wuputra, K., Ku, C., Lin, Y., Tsai, Y., Wu, D., 三井幸雄, Satou, M., Tanaka, Y., Saito, S., & Yokoyama, K. K. (2026) · BioFactors · doi:10.1002/biof.70080 · Cited by 11
“RSV has beneficial properties, including anticancer [13, 14], and antioxidant affects [15, 16] such as developments of stem cells [17] and neuron functions [13, 18] (Figure 1).”
Mahajan, K. D., Sharma, S., Gautam, R. K., Goyal, R., Mishra, D. K., & Singla, R. K. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241296557 · Cited by 7
Alzheimer’s Disease, β-Amyloid Peptides, and Ubiquitin-Proteasome System: Nutritherapeutic Insights
Simon, P. Y. R., & David, R. (2025) · Neurodegenerative Diseases · doi:10.1159/000545170 · Cited by 6
“…known for its antioxidant, anti-in fl ammatory, and neuroprotective properties, reduces the aggregation of amyloid A β 1 – 42 peptides in the hippocampus of Alzheimer ’ s patients and prevents the metabolic syndrome by activating the regulatory sirtuin SIRT-1 (silent information regulator-1) [59].”
Chowdhury, S., Kumari, G., & Jit, T. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100249 · Cited by 12
Bridging the molecular and clinical aspects of resveratrol in Alzheimer’s disease: a review
Mathew, L. S., Marathe, A., Aman, A., Vats, A., Joy, T., & Rao, Y. L. (2025) · 3 Biotech · doi:10.1007/s13205-025-04451-x · Cited by 5
“Resveratrol promotes anti-inflammatory Th2 responses, increasing anti-inflammatory cytokines while suppressing the neurodegenerative activity of M1 microglia (Gomes et al. 2018; Rao et al. 2023).”
Ahmad, S. S., & Kamal, M. A. (2019) · Protein and Peptide Letters · doi:10.2174/0929866526666190405125334 · Cited by 5
Cordone, V., Pecorelli, A., & Valacchi, G. (2022) · Redox Experimental Medicine · doi:10.1530/rem-22-0004 · Cited by 6
Weigert, H., Stuckenschneider, T., Pickert, L., Rossi, A., Meyer, A. M., Nelles, G., Schulz, R. J., Stahl, W., Schneider, S., Polidori, M. C., et al. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220039 · Cited by 5
“/day 493 for 4 weeks did not show any side effects [68, 69] and 494 may be added to multi-domain interventions.”
Zhang, L., Zhi, K., Su, Y., Peng, W., & Meng, X. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03457-x · Cited by 5
“Moreover, resveratrol can prevent a variety of chronic diseases, such as AD, PD, diabetes, tumor, obesity, and cardiovascular diseases [23, 24].”
BackgroundFood chemoprevention and air pollution: the health comes with eating
Visalli, G., Facciolà, A., Laganà, P., & Pietro, A. D. (2020) · Reviews on Environmental Health · doi:10.1515/reveh-2019-0072 · Cited by 8
“Similar neuroprotective effects are due to the antioxidant, anti-inflammatory resveratrol which protects hippocampal neurons against the toxicity of the Aβ peptides aggregates [64].”
BackgroundLloreda, C. L., Chowdhury, S., Ghura, S., Alvarez-Periel, E., & Jordan‐Sciutto, K. L. (2022) · Cells · doi:10.3390/cells11192962 · Cited by 6
“In patients with AD, various studies have found that resveratrol works to delay cognitive decline [86,87].”
BackgroundSingle‐cell digital twins identify drug targets and repurposable medicine in Alzheimer’s disease
Ren, Y., Hu, M., Li, Y. E., Pieper, A. A., Cummings, J. L., & Cheng, F. (2025) · Alzheimer s & Dementia · doi:10.1002/alz70859_102982 · Cited by 6
Kumar, A., Ramesh, M., Bhoi, J., & Govindaraju, T. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03360 · Cited by 4
Becerra, Á., Soto, F., Vallejos, A., Millán, D., Valenzuela‐Fuenzalida, J. J., León-Rojas, J. E., & Cortés, M. E. (2026) · Antioxidants · doi:10.3390/antiox15020169 · Cited by 5
TFEB, FOXO3 and TLR4 in resveratrol-induced autophagy in a mucopolysaccharidosis IIIB mouse model
Rintz, E., Podlacha, M., Gaffke, L., Jerzemowska, G., Cyske, Z., Pierzynowska, K., & Węgrzyn, G. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01643-0 · Cited by 5
Nutritional timing and stress biology: intermittent fasting as a hormetic signal for adaptation
Strilbytska, O. M., & Lushchak, O. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1778896 · Cited by 4
Zhang, N., Zhao, Z., Chen, X., Yao, H., Zhu, M., Ma, S., Wang, H., Yin, X., Zhou, Y., Zheng, C., et al. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.66 · Cited by 5
“SIRT1 has been linked to neuroprotective mechanisms across numerous neurodegenerative diseases, including AD, 82 Parkinson's disease, 83 and amyotrophic lateral sclerosis.”
InfluentialLi, H., Behnammanesh, G., Wu, Z., Rong, R., You, M., Majid, A. S. A., & Ji, D. (2022) · Disease Markers · doi:10.1155/2022/3631532 · Cited by 4
Luo, Y., Zhao, Y., Lai, J., Wei, L., Zhou, G., Yu, Y., & Liu, J. (2023) · BioMed Research International · doi:10.1155/2023/1176232 · Cited by 4
“RSV, a SIRT1 agonist, is reported to exert neuroprotection by upregulating and activating SIRT1 [27].”
BackgroundRetractedProtective role of natural products and bioactive compounds in multiple sclerosis
Bhatti, G. K., Singh, H. V., Sharma, E., Sehrawat, A., Mishra, J., Navik, U., Reddy, P. H., & Bhatti, J. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90052-2.00026-3 · Cited by 6
Effect of resveratrol on cognitive functions in older adults: a systematic review and meta-analysis
Mendoza-Núñez, V. M., Sánchez-Nieto, J. M., Sierra-Zurita, D. I., & Ruíz-Ramos, M. (2023) · Nutrición Hospitalaria · doi:10.20960/nh.04479 · Cited by 7
Amelioration of Phytanic Acid–Induced Neurotoxicity by Nutraceuticals: Mechanistic Insights
Neha, N., Chaudhary, S., Tiwari, P., & Parvez, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03985-0 · Cited by 5
“…properties due to its anti-inflammatory, anti-diabetic, anti-cancer, antioxidant, and anti-hyperlipidemic activity in addition to cardioprotective and neuroprotective properties, which make it one of the popular nutraceuticals [87, 88] which is safe and well supportable by all categories of people.”
Muzaffer, U., Gull, B., Ahmed, Z., & Ahmad, M. (2025) · Current Neuropharmacology · doi:10.2174/1570159x23666250523112027 · Cited by 6
“A defining hallmark of PD is oxidative stress, driven by an imbalance between reactive oxygen species (ROS) and the cellular antioxidant defense system.”
Liang, F., Fu, X., Li, Y., & Han, F. (2020) · AMB Express · doi:10.1186/s13568-020-01105-4 · Cited by 4
Jiang, S., Zhang, C., Lu, Y. F., & Yuan, F. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23212 · Cited by 5
Cosar, M. Y., Erdoğan, M. A., & YILMAZ, O. (2023) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2023_033 · Cited by 4
Kim, S., Kumar, V., Shin, S. J., Nam, Y., Park, Y. H., Jang, S., Park, J. Y., Kim, D. H., & Moon, M. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118876 · Cited by 4
Metadata
- Authors
- Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C.
- Affiliations
- Universidade Federal do Pará (BR)
- Corresponding author
- Monteiro, Marta Chagas
- ORCID
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 2018
- Issue
- 1
- Pages
- 8152373-8152373
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC6232815
- OpenAlex
- W2898838755
- Cited by
- 403
- References
- 170
- Citations by year
- 2026: 40 · 2025: 52 · 2024: 52 · 2023: 58 · 2022: 58 · 2021: 54 · 2020: 64 · 2019: 24
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Amazônia Paraense de Amparo à Pesquisa
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- resveratrol, Alzheimer's disease, SIRT1, neuroprotection, amyloid-beta aggregation, antioxidant activity, anti-inflammatory activity, microglial activation, M1 microglia, Th2 immune response, p53 deacetylation, neuronal apoptosis, neurogenesis, hippocampus
- MeSH terms
- Resveratrol, Alzheimer Disease, Animals, Antioxidants, Humans, Neuroprotective Agents, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.